Akebia Therapeutics | AKBA - 股本和储备

股票价格
1.40
每天变化
-0.01 -0.71%
每月一次
0%
每年
-15.15%
Q2 预测
1.36


金融业
股票价格
USD
资产
USD 376.57M
现金及等价物
USD 184.84M
销售成本
USD 10.34M
流动资产
USD 252.96M
流动负债
USD 162.94M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 32.61M
销售毛利
USD 47.28M
债务利息支出
4.83M
贷款资金
USD 48.25M
市值
USD 303.6M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 15.61M
贸易债权人
USD 21.19M
应收帐款人
USD 47.03M


股本和储备 更改 日
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Astellas Pharma JPY 1.76T 150.69B 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bayer EUR 25.95B 3.75B 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Exelixis USD 2.16B 619K 2025-12
Fresenius Medical Care EUR 249.82M 12.7B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
J&J USD 78.47B 0 2025-09
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Lexicon Pharmaceuticals USD 107.54M 12.62M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pharma Mar EUR 251.83M 54.32M 2025-12
Prothena USD 280.47M 14.51M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Tilray USD 1.58B 39.08M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09